Table 2

Responses of and outcomes for 15 CIDP patients after treatment with the proposed standardised protocol

Patient	Age at onset/sex	Initial therapy and response	Maintenance therapies and responses				Outcomes*	NIS (severe side)†
Patient	Age at onset/sex	Initial therapy and response	1	2	3	4	Outcomes*	Before treatment	After stabilisation and remission
*Duration of remission since steroids were stopped.
†Neurological impairment score; previously called the neurological disability score (described by Dyck PJ et al²); sum score of maximum severity = 120.
‡Patient in case report.
IVIg, intravenous immunoglobulin.
1‡	34/M	Plasma exchange	Oral prednisolone	Cyclophosphamide pulse	Ciclosporin		Stabilised for 26 months	51	0
		Temporarily responded	Temporarily responded, relapsed during tapering	Unchanged	Responded
2	47/M	Plasma exchange	Oral prednisolone	No therapy required			Complete remission	42	0
		Temporarily responded	Responded				(40 months)
3	59/F	Plasma exchange	Oral prednisolone	No therapy required			Complete remission	39	0
		Temporarily responded	Responded				(34 months)
4	62/M	Plasma exchange	Oral prednisolone	No therapy required			Complete remission	67	0
		Temporarily responded	Responded				(32 months)
5	46/M	IVIg	Oral prednisolone	No therapy required			Complete remission	36	0
		Rapidly responded	Responded				(29 months)
6	52/M	IVIg	Oral prednisolone	No therapy required			Complete remission	28	0
		Rapidly responded	Responded				(28 months)
7	44/F	IVIg	Oral prednisolone	No therapy required			Complete remission	46	0
		Slowly responded	Responded				(24 months)
8	11/M	IVIg	Oral prednisolone	No therapy required			Complete remission	30	0
		Rapidly responded	Responded				(18 months)
9	53/M	IVIg	Oral prednisolone	Cyclophosphamide pulse	Ciclosporin	Tacrolimus	Stabilised for 12 months;	66	12
		Temporarily responded	Unchanged, relapsed during tapering	Unchanged	Unchanged	Unchanged	maintained IVIg
10	45/F	IVIg	Oral prednisolone	Ciclosporin			Stabilised for 9 months;	37	6
		Temporarily responded	Temporarily responded, relapsed during tapering	Responded			maintained IVIg; no further relapses
11	34/F	IVIg	Oral prednisolone	Ciclosporin			Stabilised for 20 months;	45	7
		Temporarily responded	Temporarily responded, relapsed during tapering	Responded			no IVIg required; no further relapses
12	65/F	IVIg	Oral prednisolone	Ciclosporin			Stabilised for 18 months;	48	4
		Temporarily responded	Unchanged, progressed	Responded			no IVIg required; no further relapses
13	19/F	IVIg	Oral prednisolone				Stabilised for 12 months;	31	4
		Rapidly responded	Responded				no IVIg required
14	45/M	IVIg	Oral prednisolone				Stabilised for 11 months;	42	6
		Rapidly responded	Responded				no IVIg required
15	37/M	IVIg	Oral prednisolone				Stabilised for 6 months;	37	3
		Rapidly responded	Responded				no IVIg required